Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. Invion Limited
  6. Summary
    IVX   AU000000IVX4

INVION LIMITED

(IVX)
 SummaryChartsNewsCalendarCompanyFinancials 
Quotes 5-day view   End-of-day quote. End-of-day quote Australian Stock Exchange
09/13/2021 09/14/2021 09/15/2021 09/16/2021 09/17/2021 Date
0.014 0.014 0.015 0.015 0.016 Last
2592197 1414153 13833160 13406140 3100464 Volume
+16.67% 0.00% +7.14% 0.00% +6.67% Change
Estimated financial data (e)
Sales 2020 3,48 M 2,53 M 2,53 M
Net income 2020 -0,95 M -0,69 M -0,69 M
Net cash position 2020 0,62 M 0,45 M 0,45 M
P/E ratio 2020 -40,2x
Yield 2020 -
Sales 2021 2,33 M 1,69 M 1,69 M
Net income 2021 -1,48 M -1,08 M -1,08 M
Net cash position 2021 1,04 M 0,75 M 0,75 M
P/E ratio 2021 -43,5x
Yield 2021 -
Capitalization 88,6 M 64,5 M 64,4 M
EV / Sales 2020 12,5x
EV / Sales 2021 30,5x
Nbr of Employees 4
Free-Float 45,6%
More Financials
Company
Invion Limited is an Australia-based life-sciences company. The Company is focused on the development of Photosoft technology for the treatment of a range of cancers. The Company is conducting various clinical trials for the development of its Photosoft technology. Its Photo Dynamic Therapy (PDT) is a treatment that optimizes the use of non-toxic photosensitizers and visible light to kill cancer and stimulate the... 
Sector
Biotechnology & Medical Research
Calendar
09/22 | 10:00pmShareholder meeting
More about the company
All news about INVION LIMITED
08/04Invion Limited Reports Earnings Results for the Full Year Ended June 30, 2021
CI
08/04Invion Limited Auditor Raises 'Going Concern' Doubt
CI
06/02Invion Limited announced that it expects to receive AUD 4.5 million in fundin..
CI
06/01Invion Enters into A Co-Development Agreement and Exclusive Distribution and ..
CI
05/24Invion Limited Announces Initial Proof-Of-Concept Results Show INV043 to Be E..
CI
04/26Invion Limited Announces Selection of New Active Pharmaceutical Ingredient to..
CI
02/24Invion Limited Reports Earnings Results for the Half Year Ended December 31, ..
CI
2020Invion Limited Appoints Alistair Bennallack as Non-Executive Director
CI
2020Invion Limited Announces Appointment of Rob Merriel as Non-Executive Director
CI
2020Invion Limited Reports Earnings Results for the Full Year Ended June 30, 2020
CI
2020Invion Limited Auditor Raises 'Going Concern' Doubt
CI
2020Invion Limited Announces Change of Registered Office
CI
2020Invion Limited Announces Management Changes, Effective July 31, 2020
CI
2020Invion Limited Announces Business Update to the Forward R&D Plan
CI
2020Invion Limited Announces Executive Changes, Effective October 31, 2020
CI
More news
News in other languages on INVION LIMITED

- No features available -

More news
Chart INVION LIMITED
Duration : Period :
Invion Limited Technical Analysis Chart | IVX | AU000000IVX4 | MarketScreener
Income Statement Evolution
Managers and Directors
Thian Chew Chairman & Chief Executive Officer
Melanie Jaye Leydin Chief Financial Officer & Secretary
Alan Yamashita Non-Executive Director
Rob Merriel Non-Executive Director
Alistair Bennallack Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
INVION LIMITED60.00%64
MODERNA, INC.311.65%173 588
LONZA GROUP AG32.35%60 074
IQVIA HOLDINGS INC.43.07%49 116
CELLTRION, INC.-23.26%31 904
SEAGEN INC.-10.81%28 420